Eventide Gilead Class C (ETCGX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
44.89
-0.67 (-1.47%)
Jun 13, 2025, 4:00 PM EDT
6.91% (1Y)
Fund Assets | 3.78B |
Expense Ratio | 2.16% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 0.64 |
Dividend Yield | 1.44% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Dec 13, 2024 |
Previous Close | 45.56 |
YTD Return | 4.66% |
1-Year Return | 8.45% |
5-Year Return | 29.67% |
52-Week Low | 34.85 |
52-Week High | 47.00 |
Beta (5Y) | n/a |
Holdings | 76 |
Inception Date | Oct 28, 2009 |
About ETCGX
The Eventide Gilead Class C (ETCGX) seeks to provide long-term capital appreciation. ETCGX invests primarily in a broad range of equity securities without limitation to market capitalization. ETCGX seeks to invest in attractively valued securities that, in its opinion, represent above-average long-term investment opportunities.
Category Mid-Cap Growth
Stock Exchange NASDAQ
Ticker Symbol ETCGX
Share Class Class C
Index Russell MidCap Growth TR
Performance
ETCGX had a total return of 8.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.22%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
29.03% of assetsName | Symbol | Weight |
---|---|---|
Verona Pharma plc | VRNA | 4.78% |
Guardant Health, Inc. | GH | 3.90% |
Toast, Inc. | TOST | 3.11% |
Xometry, Inc. | XMTR | 2.99% |
Old Dominion Freight Line, Inc. | ODFL | 2.58% |
Mirum Pharmaceuticals, Inc. | MIRM | 2.57% |
Trane Technologies plc | TT | 2.55% |
Waste Connections, Inc. | WCN | 2.38% |
Global-E Online Ltd. | GLBE | 2.09% |
RB Global, Inc. | RBA | 2.08% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 13, 2024 | $0.6441 | Dec 16, 2024 |
Dec 15, 2022 | $2.2812 | Dec 16, 2022 |
Dec 16, 2021 | $4.2652 | Dec 17, 2021 |
Dec 17, 2020 | $0.5114 | Dec 17, 2020 |
Dec 17, 2019 | $1.3176 | Dec 17, 2019 |
Dec 18, 2018 | $1.7132 | Dec 18, 2018 |